Walleye Capital LLC Eagle Pharmaceuticals, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $178,724 - $312,364	-5,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $239,008 - $282,964	-4,400 Reduced 45.83%	5,200 $312,000
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $218,325 - $245,918	4,100 Added 74.55%	9,600 $543,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $18,644 - $23,380	400 Added 7.84%	5,500 $306,000
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $197,165 - $264,282	5,100 New	5,100 $257,000

8.56M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $9.11M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.